Inside the AESTURA ATOBARRIER365 Cream: What 42 Ingredients and Four Years of Price Data Actually Show

A 80 ml barrier cream from AMOREPACIFIC's derm line, built on a ceramide-fatty-acid-cholesterol triad and sold as the go-to moisturiser for compromised, sensitive skin. It is one of the highest-volume Korean moisturisers on the US marketplace, holds an eczema-association acceptance, and has been price-tracked since June 2022. It is also a cream that a specialist skincare community rates far more harshly than the marketplace does - and that gap is the most interesting thing in the data.

1. The Product

1.1 Specification

1.2 The brand's case

• Ceramide capsules. High-density ceramides delivered through capsule technology that the brand says replenishes the moisture barrier in sensitive skin for deep, long-lasting hydration.
• Triple lipid complex. Ceramides, fatty acids and cholesterol together - the same three lipid classes the skin builds its own barrier from.
• Hydration for dry, normal and sensitive skin. Vitamin E and squalane named as the supporting actives, with an immediate-comfort claim.
• Derm-tested and non-comedogenic tested. Allergy-tested, free of fragrance, colourants and mineral oils, accepted by the National Eczema Association, and positioned as usable after microneedling.
• Volume claim. One unit sold every seven seconds in Korea across a five-million-unit period.

1.3 Product images

The first frame is the packaging: a white tube with a diagonal blue lower half, the wordmark in blue capitals, and the ceramide seal printed near the crimp. The second is a textural proof shot - a thick white swatch on a bare cheek, annotated with the 120-hour hydration figure, the dermatologist-tested line, and two award badges. The third is the formula diagram: a ribbon of cream leaving the nozzle with three labelled anchors pointing at fatty acids, ceramides and cholesterol.

1.4 Texture and routine position

A cream, so it closes a routine after serum and before sunscreen in the morning, or last at night. Buyers describe it as smooth and non-greasy on application with quick absorption despite a heavy-looking swatch, and the ingredient base explains that combination: squalane esters and dicaprylyl carbonate for slip, dimethicone for the non-greasy finish, and a fatty-acid soap structure for body. It layers over hydrating essences and under sunscreen without pilling in the reports that mention it.

2. What Buyers Report

2.1 Two ratings that disagree

The marketplace distribution is close to a ceiling: 83% five-star against 3% one-star, with only 2% at two stars. That shape is what a product looks like when it reliably does its one job for the majority of buyers. The specialist rating of 3.6 does not contradict it - it measures a different question. A community that reads ingredient lists will mark down a cream for containing oleic acid at comedogenic 5 and for triggering reactions in 58 of 184 sensitivity mentions, even while acknowledging that it hydrates exceptionally well.

2.2 Aspect by aspect

The two highest-volume aspects - moisturising at 683 mentions and effectiveness at 653 - are also the two highest-scoring, at 89% and 93%. That is the strongest possible version of this pattern: the thing people talk about most is the thing they are happiest with. Texture at 92% over 202 mentions confirms the sensory experience is not contested.

The soft spot is not what a reader might expect. Skin sensitivity is the fourth most-discussed aspect at 184 mentions and sits at 68% - meaning 58 individual complaints about reactions, on a product whose entire positioning is sensitive-skin safety. That is a real signal, not a rounding artefact, and it is exactly the aspect that the specialist community's 3.6 rating is picking up. Value for money at 62% is the lower score but the weaker signal: at $32.00 for 80 ml the per-ounce math is $11.85, which is expensive for a pharmacy-adjacent moisturiser and cheap for a derm-brand ceramide cream, so the split is a positioning argument rather than a product failure.

3. What Is Inside

Two independent ingredient databases were merged for this section. One grades every INCI entry on acne risk, irritation and a safety grade where 1 is safest; the other publishes claim badges, concerns, benefit counts and its own comedogenic ratings. Both list the same 42 ingredients in the same order, which makes this the cleanest cross-check in the report.

3.1 Claim badges

Alcohol freeEU allergen freeFragrance freeOil freeParaben freeSulfate freeReef safeVeganCruelty free (brand claim)

Not silicone freeNot fungal-acne safePotential pore cloggers found

3.2 Ingredient levels

Each row was graded from its safety value, reading ranges on the upper bound. The scale is inverted - level 1 is the cleanest grade.

The safety picture is solid: 30 of 41 graded rows sit at the lowest grade, and the only genuinely wide bands belong to a silicone and three emulsifier-or-pH ingredients whose ranges reflect source disagreement. Where this formula is not clean is the acne axis. Thirty-nine percent of the graded rows carry a comedogenic rating and four of those are at 3 or above, all of them in the fatty-acid and ester cluster that forms the oil phase. So the correct reading is narrow: this is a low-irritation, high-comedogenic-potential cream. Those two properties are not in tension - occlusion is the mechanism.

3.3 What is flagged, and why

Three things are absent and worth stating because their absence is the formula's main safety argument: no drying alcohol, no fragrance and no parfum allergens, no parabens. For a cream aimed at eczema and post-procedure skin, removing the fragrance allergen set is the single most consequential formulation choice available, and it was made.

3.4 Key ingredient groups

Every headline group holds exactly one ingredient. That is not a weakness in the formula - the ceramide work here is done by one ceramide plus two ceramide-like amides (hydroxypropyl bispalmitamide MEA and hydroxypropyl bislauramide MEA) plus cholesterol plus phytosphingosine and sphingolipids, which is a broader lipid reconstruction than the "one ceramide" count suggests. It is, however, a weakness in the marketing: there is no multi-active story to tell here, which is why the brand sells mechanism (triple lipid complex, capsules) rather than an ingredient list.

3.5 The full 42

Both databases side by side, in INCI order. Safety is inverse: 1 is safest. A dash means unrated, not risk-free.

Coverage is 42 of 42 from both databases, in the same order. Four rows carry a range, and the two databases disagree in direction on two of them: stearic acid is 2 in one and 2-3 in the other, tocopherol is 2-3 and 0-3. Both readings are shown rather than reconciled, because picking one would hide the disagreement. Two rows carry no numbers at all in one database and a rating in the other - silica is fully unrated on both axes, and oleic acid's comedogenic 5 has no counterpart in the second database's unrated row. Where the two disagree, treat the rating as directional evidence and not as a measurement.

3.6 Do the benefit claims survive the formula?

4. What It Costs

4.1 Today's price

There is no discount on this listing. The price equals the reference list price, the subscription price is the standard 10% incentive, and the per-ounce figure of $11.85 is what a buyer is really paying for a derm-brand ceramide cream in a small tube. That number explains the value-for-money aspect sitting at 62%: an 80 ml tube at $32 is not expensive in absolute terms, but it is expensive per ounce relative to the pharmacy brands it competes with, and it is cheap per ounce relative to prestige ceramide creams.

4.2 Four years of tracked prices

A long-run price tracker was read for this listing. Both the Amazon-sold channel and the third-party new channel carry history - unusual for an imported Korean SKU - and there is no used market.

The bars separate two very different pricing regimes. Amazon's own channel is narrow and disciplined: a $9.94 spread over four years and an average within 3% of list. The third-party channel is four times wider in relative terms, with a $56.99 spike and a $22.00 trough bracketing a $29.02 average. What a buyer actually pays is the brand-controlled price, and the third-party noise is mostly a side-show.

Both April 2025 extremes are suspicious. The third-party high of $56.99 is dated 2025-04-06 and the Amazon high of $35.94 is dated 2025-04-07 - one day apart, on both channels, at the top of their ranges. Two channels hitting all-time highs within 24 hours of each other is the signature of a supply event or a data artefact across the listing, not of organic pricing. Neither should anchor a valuation. The $22.00 low in October 2024 is more likely a real promotional moment.

4.3 Where today's price sits

Today's price is the brand's price, undiscounted, and it is 10.3% above the four-year third-party average. On this record there is no discount to capture by waiting for a normal cycle - the price does not move. The only genuinely cheaper window in four years was Amazon's own $26.00 in June 2025, which is a 19% saving against today and worth waiting for if the purchase is not urgent. The tracked current value is dated June 2026, four months before this capture, so treat it as the brand's standing price rather than as a live quote.

5. Who It Suits

This is a barrier reconstruction cream, not a treatment. Its lipid architecture - ceramide NP, two ceramide analogues, cholesterol, phytosphingosine, sphingolipids and four fatty acids - is a more complete reconstruction of the skin's own lipid mix than most ceramide creams attempt, and that is what the 89% moisturising and 93% effectiveness scores are responding to. It is fragrance-free, alcohol-free and allergen-free, which is exactly right for the population it targets. Against that, it is occlusive by design, contains a silicone at position 10, and carries oleic acid at comedogenic 5 near the end of the list.

6. How This Was Built

6.1 Sources and sequence

Four channels were read on 2026-10-27. The live retail listing was read under a New York 10001 delivery address so that every price is native USD with no conversion. A long-run price tracker supplied the historical band. Two independent ingredient databases were merged: one grading all 42 INCI entries on acne, irritation and safety, and one publishing claim badges, concerns, benefit counts and its own comedogenic ratings. Both returned 42 of 42 ingredients in the same order, which is the strongest cross-check available across the four channels.

6.2 Confidence

6.3 What this report cannot tell you

1. The price history block is all-time for every chart window. No period-specific low, high or average exists in that source, and none is stated here.
2. The 3rd-party current value is four months old and the Amazon channel has no current value at all. The live listing price of $32.00 is the number to buy at.
3. Individual review bodies and buyer photographs did not render at capture time. The review analysis rests on published aggregates, and no buyer-photo gallery appears because the listing rendered none.
4. Ingredient grades are community assessments. A blank cell is missing data; a low grade is not a safety guarantee; a range is disagreement, not precision.
5. Two of the twelve benefit claims are genuinely contradicted by the formula. That judgement is this report's reading of the evidence, not a claim by any source.
6. Every figure is a snapshot. Ratings, ranks and prices move between captures.